Procter & Gamble Health Ltd (PGHL) has announced a board meeting where the financial results for the quarter ended June 30, 2025, were approved. The company reported Revenue from Operations at ₹338.74 Cr, a healthy increase from ₹283.88 Cr in the same period last year. Net Profit for the quarter surged to ₹66.18 Cr, significantly up from ₹16.78 Cr in the prior year's corresponding quarter. This strong growth reflects solid operational improvements, partly due to the absence of last year's exceptional asset impairment. Basic and Diluted EPS stood at ₹39.87.